Purpose
This is a project to provide investment opportunities for new target anti-cancer drug development.
Investment target
The target is a spin-out venture established by the R & D executives from Roche and Novartis.
Outline
This company is the world's highest level RNA-related drug discovery company. They have strong partnerships with Roche and Novartis, and their funding needs are not so high but still this investment may be good opportunities.